EMERYVILLE, Calif.,
Jan. 5, 2022 /PRNewswire/ -- Amyris,
Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company
accelerating the world's transition to sustainable consumption
through its Lab-to-Marketâ„¢ operating platform, today announced that
management will present at the 40th Annual J.P. Morgan
Healthcare Conference on Wednesday, January
12, 2022, at 11:15 am ET.
A live webcast of the presentation and a replay will be
available on the Investor Relations section of the company's
website at
https://investors.amyris.com/events-and-presentations.
About Amyris
Amyris is a leading synthetic biotechnology company,
transitioning the Clean Health & Beauty and Flavors &
Fragrances markets to sustainable ingredients through fermentation
and the company's proprietary Lab-to-Marketâ„¢ operating platform.
This Amyris platform leverages state-of-the-art machine learning,
robotics and artificial intelligence, enabling the company to
rapidly bring new innovation to market at commercial scale. Amyris
ingredients are included in over 20,000 products from the world's
top brands, reaching more than 300 million consumers. Amyris also
owns and operates a family of consumer brands that is constantly
evolving to meet the growing demand for sustainable, effective and
accessible products.
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amyris-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301454301.html
SOURCE Amyris, Inc.